Health Condition 1: I499- Cardiac arrhythmia, unspecified
Conditions
Interventions
Intervention1: Dexmedetomidine: Dexmedetomidine administered at a dose of 1 g/kg over 10 minutes during rewarming in cardiopulmonary bypass surgery.
Control Intervention1: Not applicable: Not applica
Sponsors
Dr Kamna Nagar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for elective valve replacement surgery 2. Adult patients scheduled for congenital cardiac surgery 3. Patients providing written informed consent
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the incidence of arrhythmias post long cardiopulmonary bypass exposure. This includes monitoring ECG changes, heart rate, and the occurrence of arrhythmias (such as premature ventricular contractions, atrial fibrillation, and ventricular tachycardia) before induction, during surgery, and in the postoperative ICU period.Timepoint: 36 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Advantage in fast-tracking recovery , Evaluating whether dexmedetomidine facilitates earlier extubation & ICU discharge. 2. Reduction in the use of long acting anti-arrhythmic drug infusions Specifically assessing the decreased need for amiodarone or other anti-arrhythmic medications postoperatively.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDR Dinesh Kaushal
King Georges Medical University Lucknow
Outcome results
None listed